Clinical Trial

Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease (Version 3.0)

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 24, 2025 (before its estimated May 5, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to explore the efficacy of CMNT, an intermittent energy restriction (iER) intervention, in managing Chinese adults with type 2 diabetes and non-alcoholic fatty liver disease. An interim analysis will be added to the planned 120-participant CMNT intervention program to compare intervention efficacy with the usual care control group and assess potential risks associated with dietary interventions.
Trial Details
NCT Number NCT07083336
Lead Sponsor State Key Laboratory of Subhealth Intervention Technology
Conditions Type 2 Diabetes Mellitus, Metabolic Dysfunction-associated Steatotic Liver Disease
Enrollment 120 participants
Start Date 2022-06-05
Primary Completion 2026-05-05 (estimated)
Study Completion 2026-06-05 (estimated)
Updated on ClinicalTrials.gov 2025-07-24